Allianz Asset Management
IMNM icon

Allianz Asset Management’s Immunome IMNM Stock Holding History

Allianz Asset Management’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-43,400
Closed -$1.07M – 2188
2024
Q1 		$1.07M Buy
+43,400
New +$881K ﹤0.01% 1390

Other funds holding IMNM

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Allianz Asset Management's IMNM Position: Q2 2024 in Review

Allianz Asset Management sold out of Immunome (IMNM) in Q2 2024, closing a stake of 43,400 shares — an estimated $1.07M sold.

Allianz Asset Management first reported a position in IMNM in Q1 2024 and held it in 1 quarter. The position peaked at $1.07M in Q1 2024. 113 funds tracked by Wall St. Rank hold IMNM as of Q2 2024.

  • Allianz Asset Management reported no remaining Immunome position as of Q2 2024 after selling out during the quarter.
  • Allianz Asset Management sold 43,400 Immunome shares in Q2 2024, an estimated $1.07M.
  • Allianz Asset Management first reported a position in Immunome in Q1 2024 and held it in 1 quarter.
  • Allianz Asset Management's Immunome position peaked at $1.07M in Q1 2024.
  • 113 funds tracked by Wall St. Rank held Immunome as of Q2 2024.

Based on Allianz Asset Management's 13F filing for Q2 2024, filed 13 Aug 2024.